Self-Management Support for Lung Cancer Patients With Cachexia
Efficacy of Self-Management Support on Nutritional Status in Lung Cancer Patients With Cancer Cachexia Syndrome: A Randomized Clinical Trail
1 other identifier
interventional
104
1 country
2
Brief Summary
The goal of this randomized clinical trial is to evaluate the efficacy of a self-management support program combining exercise and nutrition intervention for lung cancer patients with cancer cachexia anorexia syndrome. This study is conducted in two stages. In the first stage (Pilot Phase), the researchers aim to assess the feasibility of the intervention and its potential impact on nutritional status in 20 participants. Based on these preliminary results, the intervention protocol or supervision model may be refined for the subsequent full-scale trial. The main questions it aims to answer are: Is the combined exercise and nutrition self-management support program feasible for lung cancer patients with cachexia? Can this integrated intervention improve the nutritional status of these patients compared to routine care? Participants in the intervention group will receive self-management support-based education to develop personalized exercise plans and ensure adequate protein intake. The researchers will compare this group to a control group receiving routine health education to evaluate differences in nutritional outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2023
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 20, 2023
CompletedFirst Submitted
Initial submission to the registry
January 23, 2023
CompletedFirst Posted
Study publicly available on registry
February 16, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2027
May 13, 2026
May 1, 2026
3.9 years
January 23, 2023
May 11, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change from baseline Mini Nutrition Assessment(MNA)
The MNA consists of 18 self-reported questions covering ingestion, weight loss, mobility, acute illness/stress, neuropsychological problems, BMI, living arrangements, polypharmacy, skin ulcers, meal frequency, food/fluid intake, and mode of feeding. The maximal score is 30. A score \>23.5 means well-nourished, 17-23.5 means risk of malnutrition, and \<17 means malnutrition. Higher scores indicate better nutritional status.
baseline, Week 8, Week 12.
Secondary Outcomes (11)
Feasibility of the self-management support program
Week 12
Change from balseline in Body Mass Index(BMI)
Baseline, Week 8, Week 12
Change from baseline in skeletal muscle mass
Baseline, Week 8, Week 12
Change from basleline body fat mass at 12weeks
Baseline, Week 8, Week 12
Change from Baseline in Upper Body Muscle Endurance (30-Second Arm Curl Test)
Baseline, Week 8, Week 12
- +6 more secondary outcomes
Study Arms (2)
Combined Exercise and Nutrition Self-management Support Program
EXPERIMENTALParticipants receive a 12-week multimodal intervention. This includes personalized exercise prescriptions (aerobic, resistance, and flexibility training) guided by wearable technology and structured nutritional counseling focused on adequate protein intake (e.g., 1.2 g/kg/day). All activities are supported by a self-management behavioral framework to enhance adherence. In addition, both arms receive baseline cancer care from hospital case managers to ensure ethical standards of care are met.
Routine health education group
NO INTERVENTIONParticipants will receive standard of care provided by cancer case managers, including education on medication adherence, symptom/side-effect management, and nutritional supplement trials as needed. To maintain study blinding, participants in this group will also wear Xiaomi smart bands and undergo the same assessment schedule (Baseline, Week 8, Week 12) without the additional self-management support program.
Interventions
A structured 12-week multimodal support program. (1) Exercise: Personalized home-based aerobic, resistance, and flexibility training (at least 3 times/week, 30 min/session) monitored via Xiaomi smart bands. (2) Nutrition: Goal-oriented counseling focused on achieving a high-protein intake (e.g., 1.2-1.5 g/kg/day). (3) Self-management: Continuous support using a self-monitoring manual, wearable device feedback, and a dedicated Line@ social media platform for real-time interaction with researchers, providing counseling and symptom management support to enhance patient adherence.
Eligibility Criteria
You may qualify if:
- Diagnosed lung cancer(ICD-10 code: C33-C34)
- Body weight loss: body weight loss 2% before recruitment 2 months or body weight loss 5% before recruitment 6months.
- Physician judged may do home exercise without supervisor.
- Has smart phone and agree to use exercise associated application.
- Agree to wear Xioami smart band as long as passible.
- Conscious clear and communication.
- Eastern Cooperative Oncology Group (ECOG) 0-1.
You may not qualify if:
- Participants with cardiovascular disease can't exercise without supervisor.
- Diabetes Mellitus with blood sugar poor control.
- Chronic obstructive pulmonary disease with dyspnea on exertion.
- Platelets \< 50000mm3 due to disease or treatment.
- Hemoglobin \<10mg/dl.
- Recently stumble, severe pain, cognitive and behavior change.
- Suspect or diagnosed brain metastasis.
- Suspect or diagnosed bone metastasis.
- Receive Nasogastric tube feeding or parenteral nutrition.
- Physician judged can't do home exercise.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Changhua Christian Hospital
Changhua, Changhua, 51052, Taiwan
Taipei Veterans General Hospital
Taipei, Taipei, 11219, Taiwan
Related Publications (8)
Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, Jatoi A, Loprinzi C, MacDonald N, Mantovani G, Davis M, Muscaritoli M, Ottery F, Radbruch L, Ravasco P, Walsh D, Wilcock A, Kaasa S, Baracos VE. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011 May;12(5):489-95. doi: 10.1016/S1470-2045(10)70218-7. Epub 2011 Feb 4.
PMID: 21296615BACKGROUNDAnderson LJ, Albrecht ED, Garcia JM. Update on Management of Cancer-Related Cachexia. Curr Oncol Rep. 2017 Jan;19(1):3. doi: 10.1007/s11912-017-0562-0.
PMID: 28138933BACKGROUNDOzaki H, Nakagata T, Yoshihara T, Kitada T, Natsume T, Ishihara Y, Deng P, Kobayashi H, Machida S, Naito H. Effects of Progressive Walking and Stair-Climbing Training Program on Muscle Size and Strength of the Lower Body in Untrained Older Adults. J Sports Sci Med. 2019 Nov 19;18(4):722-728. eCollection 2019 Dec.
PMID: 31827357BACKGROUNDMuscaritoli M, Arends J, Bachmann P, Baracos V, Barthelemy N, Bertz H, Bozzetti F, Hutterer E, Isenring E, Kaasa S, Krznaric Z, Laird B, Larsson M, Laviano A, Muhlebach S, Oldervoll L, Ravasco P, Solheim TS, Strasser F, de van der Schueren M, Preiser JC, Bischoff SC. ESPEN practical guideline: Clinical Nutrition in cancer. Clin Nutr. 2021 May;40(5):2898-2913. doi: 10.1016/j.clnu.2021.02.005. Epub 2021 Mar 15.
PMID: 33946039RESULTCampbell KL, Winters-Stone KM, Wiskemann J, May AM, Schwartz AL, Courneya KS, Zucker DS, Matthews CE, Ligibel JA, Gerber LH, Morris GS, Patel AV, Hue TF, Perna FM, Schmitz KH. Exercise Guidelines for Cancer Survivors: Consensus Statement from International Multidisciplinary Roundtable. Med Sci Sports Exerc. 2019 Nov;51(11):2375-2390. doi: 10.1249/MSS.0000000000002116.
PMID: 31626055RESULTPeddle-McIntyre CJ, Singh F, Thomas R, Newton RU, Galvao DA, Cavalheri V. Exercise training for advanced lung cancer. Cochrane Database Syst Rev. 2019 Feb 11;2(2):CD012685. doi: 10.1002/14651858.CD012685.pub2.
PMID: 30741408RESULTArends J, Bachmann P, Baracos V, Barthelemy N, Bertz H, Bozzetti F, Fearon K, Hutterer E, Isenring E, Kaasa S, Krznaric Z, Laird B, Larsson M, Laviano A, Muhlebach S, Muscaritoli M, Oldervoll L, Ravasco P, Solheim T, Strasser F, de van der Schueren M, Preiser JC. ESPEN guidelines on nutrition in cancer patients. Clin Nutr. 2017 Feb;36(1):11-48. doi: 10.1016/j.clnu.2016.07.015. Epub 2016 Aug 6.
PMID: 27637832RESULTSchreiber M, Bucher T, Collins CE, Dohle S. The Multiple Food Test: Development and validation of a new tool to measure food choice and applied nutrition knowledge. Appetite. 2020 Jul 1;150:104647. doi: 10.1016/j.appet.2020.104647. Epub 2020 Feb 29.
PMID: 32119883RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Li Chun Chang, Master
Changhua Christian Hospital
- STUDY DIRECTOR
Tsae Jyy Wang, PhD
National Taipei University of Nursing and Health Sciences
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- To maintain blinding, all participants are provided with wearable devices and undergo identical assessment protocols. They are informed that personalized health education will be delivered at varying intervals based on clinical results, which prevents them from distinguishing between the experimental and control intervention models.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Head of nurse practitioner
Study Record Dates
First Submitted
January 23, 2023
First Posted
February 16, 2023
Study Start
January 20, 2023
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2027
Last Updated
May 13, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will not share
Due to ethical restrictions and the terms of the informed consent form, individual participant data will not be shared with third parties.